Ambulatory Polysomnography Systems Market By Product, By Application, By End-user : Global Opportunity Analysis and Industry Forecast, 2022-2031

Description

List of Tables

According to a new report published by Allied Market Research, titled, "Ambulatory Polysomnography (Psg) Systems Market," The ambulatory polysomnography (psg) systems market was valued at $327.00 million in 2021, and is estimated to reach $570.7 million by 2031, growing at a CAGR of 6% from 2022 to 2031.

Ambulatory Polysomnography Systems Market - IMG1

Ambulatory polysomnography (Amb-PSG), also known as type II PSG, can be used to identify different sleep disorders by characterizing sleep stages and quantifying arousals, total sleep time (TST), and an accurate respiratory disturbance index (RDI). Ambulatory polysomnography systems are in high demand among patients suffering from a variety of sleep disorders due to the benefits they provide. This is propelling the ambulatory polysomnography systems market.

The majority of the population, particularly in rural regions, is uninformed of the dangers of sleep apnea. Sleep disorders that go untreated can lead to chronic ailments like heart failure, stroke, high blood pressure, diabetes, and obesity. This can result in major health issues such as uncontrolled blood pressure, heart attacks, weakened and restricted blood vessels in the kidneys, and aneurysms. The population's lack of awareness about sleeping difficulties is expected to stymie the growth of the ambulatory polysomnography systems market in the near future.

Technological improvements in the sleep care business can be identified as a driving force in this market. The ambulatory polysomnography systems market is growing steadily due to numerous revolutionary technologies such as portable devices, smartphone applications, telemedicine, and so on. Wireless and portable polysomnography systems, like as Nox Medical's Nox A1s PSG, have benefited from research and development. Wireless capabilities give patients with a sense of liberty by allowing them freedom of movement while they are being diagnosed. This will have a beneficial impact on the growth of the ambulatory polysomnography systems market.

The global market has benefited by the outbreak of the COVID-19 pandemic. Key participants claimed considerable revenue growth as a result of an increase in the number of patients suffering from sleep difficulties as a result of the COVID19 pandemic. According to the poll, 70% of respondents have experienced one or more new sleep issues since the start of the COVID-19, leading to an increase in the use of sleep apnea equipment. As a result of this, the PSG systems' businesses launched a clinically certified, low-touch CPAP Mask Selector tool that can be utilized remotely from the patient's home.

The key players profiled in this report include: Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Lowenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual / Sleepvirtual.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ambulatory polysomnography (psg) systems market analysis from 2021 to 2031 to identify the prevailing ambulatory polysomnography (psg) systems market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the ambulatory polysomnography (psg) systems market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global ambulatory polysomnography (psg) systems market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Up to 12 Channel PSG Systems
Up to 24 Channel PSG Systems
Up to 32 Channel PSG Systems
Above 32 Channel PSG Systems

By Application

Obstructive Sleep
Apnea Narcolepsy
Chronic Insomnia
Others

By End-user

Hospitals
Sleep Laboratories
Home Care Settings

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- United Arab Emirates
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Cadwell Industries Inc.
Compumedics Limited
Compumedics Limited
Koninklijke Philips N.V.
Lowenstein Medical Technology GmbH + Co. KG.
Natus Medical Incorporated
neurosoft
Nihon Kohden Corporation
Nox Medical
SOMNOmedics GmbH

Product Code: A31898

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Average Selling Price
3.7. Brand Share Analysis
3.8. Key Regulation Analysis
3.9. Market Share Analysis
3.10. Patent Landscape
3.11. Regulatory Guidelines
3.12. Value Chain Analysis

CHAPTER 4: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Up to 12 Channel PSG Systems
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Up to 24 Channel PSG Systems
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Up to 32 Channel PSG Systems
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
4.5. Above 32 Channel PSG Systems
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country

CHAPTER 5: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Obstructive Sleep
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Apnea Narcolepsy
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Chronic Insomnia
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Sleep Laboratories
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Home Care Settings
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End-user
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Key market trends, growth factors and opportunities
  - 7.2.5.1.2. Market size and forecast, by Product
  - 7.2.5.1.3. Market size and forecast, by Application
  - 7.2.5.1.4. Market size and forecast, by End-user
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Key market trends, growth factors and opportunities
  - 7.2.5.2.2. Market size and forecast, by Product
  - 7.2.5.2.3. Market size and forecast, by Application
  - 7.2.5.2.4. Market size and forecast, by End-user
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Key market trends, growth factors and opportunities
  - 7.2.5.3.2. Market size and forecast, by Product
  - 7.2.5.3.3. Market size and forecast, by Application
  - 7.2.5.3.4. Market size and forecast, by End-user
7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End-user
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Key market trends, growth factors and opportunities
  - 7.3.5.1.2. Market size and forecast, by Product
  - 7.3.5.1.3. Market size and forecast, by Application
  - 7.3.5.1.4. Market size and forecast, by End-user
  - 7.3.5.2. UK
  - 7.3.5.2.1. Key market trends, growth factors and opportunities
  - 7.3.5.2.2. Market size and forecast, by Product
  - 7.3.5.2.3. Market size and forecast, by Application
  - 7.3.5.2.4. Market size and forecast, by End-user
  - 7.3.5.3. France
  - 7.3.5.3.1. Key market trends, growth factors and opportunities
  - 7.3.5.3.2. Market size and forecast, by Product
  - 7.3.5.3.3. Market size and forecast, by Application
  - 7.3.5.3.4. Market size and forecast, by End-user
  - 7.3.5.4. Spain
  - 7.3.5.4.1. Key market trends, growth factors and opportunities
  - 7.3.5.4.2. Market size and forecast, by Product
  - 7.3.5.4.3. Market size and forecast, by Application
  - 7.3.5.4.4. Market size and forecast, by End-user
  - 7.3.5.5. Italy
  - 7.3.5.5.1. Key market trends, growth factors and opportunities
  - 7.3.5.5.2. Market size and forecast, by Product
  - 7.3.5.5.3. Market size and forecast, by Application
  - 7.3.5.5.4. Market size and forecast, by End-user
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Key market trends, growth factors and opportunities
  - 7.3.5.6.2. Market size and forecast, by Product
  - 7.3.5.6.3. Market size and forecast, by Application
  - 7.3.5.6.4. Market size and forecast, by End-user
7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End-user
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. China
  - 7.4.5.1.1. Key market trends, growth factors and opportunities
  - 7.4.5.1.2. Market size and forecast, by Product
  - 7.4.5.1.3. Market size and forecast, by Application
  - 7.4.5.1.4. Market size and forecast, by End-user
  - 7.4.5.2. Japan
  - 7.4.5.2.1. Key market trends, growth factors and opportunities
  - 7.4.5.2.2. Market size and forecast, by Product
  - 7.4.5.2.3. Market size and forecast, by Application
  - 7.4.5.2.4. Market size and forecast, by End-user
  - 7.4.5.3. India
  - 7.4.5.3.1. Key market trends, growth factors and opportunities
  - 7.4.5.3.2. Market size and forecast, by Product
  - 7.4.5.3.3. Market size and forecast, by Application
  - 7.4.5.3.4. Market size and forecast, by End-user
  - 7.4.5.4. South Korea
  - 7.4.5.4.1. Key market trends, growth factors and opportunities
  - 7.4.5.4.2. Market size and forecast, by Product
  - 7.4.5.4.3. Market size and forecast, by Application
  - 7.4.5.4.4. Market size and forecast, by End-user
  - 7.4.5.5. Australia
  - 7.4.5.5.1. Key market trends, growth factors and opportunities
  - 7.4.5.5.2. Market size and forecast, by Product
  - 7.4.5.5.3. Market size and forecast, by Application
  - 7.4.5.5.4. Market size and forecast, by End-user
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Key market trends, growth factors and opportunities
  - 7.4.5.6.2. Market size and forecast, by Product
  - 7.4.5.6.3. Market size and forecast, by Application
  - 7.4.5.6.4. Market size and forecast, by End-user
7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End-user
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Key market trends, growth factors and opportunities
  - 7.5.5.1.2. Market size and forecast, by Product
  - 7.5.5.1.3. Market size and forecast, by Application
  - 7.5.5.1.4. Market size and forecast, by End-user
  - 7.5.5.2. United Arab Emirates
  - 7.5.5.2.1. Key market trends, growth factors and opportunities
  - 7.5.5.2.2. Market size and forecast, by Product
  - 7.5.5.2.3. Market size and forecast, by Application
  - 7.5.5.2.4. Market size and forecast, by End-user
  - 7.5.5.3. Saudi Arabia
  - 7.5.5.3.1. Key market trends, growth factors and opportunities
  - 7.5.5.3.2. Market size and forecast, by Product
  - 7.5.5.3.3. Market size and forecast, by Application
  - 7.5.5.3.4. Market size and forecast, by End-user
  - 7.5.5.4. South Africa
  - 7.5.5.4.1. Key market trends, growth factors and opportunities
  - 7.5.5.4.2. Market size and forecast, by Product
  - 7.5.5.4.3. Market size and forecast, by Application
  - 7.5.5.4.4. Market size and forecast, by End-user
  - 7.5.5.5. Rest of LAMEA
  - 7.5.5.5.1. Key market trends, growth factors and opportunities
  - 7.5.5.5.2. Market size and forecast, by Product
  - 7.5.5.5.3. Market size and forecast, by Application
  - 7.5.5.5.4. Market size and forecast, by End-user

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

9.1. Koninklijke Philips N.V.
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
9.2. Natus Medical Incorporated
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
9.3. Nihon Kohden Corporation
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
9.4. Nox Medical
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
9.5. Lowenstein Medical Technology GmbH + Co. KG.
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
9.6. neurosoft
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
9.7. Cadwell Industries Inc.
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
9.8. SOMNOmedics GmbH
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
9.9. Compumedics Limited
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
9.10. Compumedics Limited
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot